Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Primary Care Reports

RSS  

Articles

  • Clinical Briefs in Primary Care Supplement

  • Pharmacology Watch: FDA Approves Claritin For OTC Use For Seasonal Rhinitis

    FDA Approves Claritin For OTC Use For Seasonal Rhinitis; Simpler Atrial Fibrillation Management; Oral Anticoagulation Vs Aspirin in AF; Immunization Does Not Cause Autism; Statins May Lower CRP Levels; Simvastatin Reduced CRP Plasma Levels; FDA Actions
  • An Overview of the Science and Practice of Humor — HA!

    A humor agenda may prove to be an indispensable part of the health care package for both the receivers and providers of medical care! The following article will include some effective examples of how to turn glum into fun.
  • Clinical Briefs in Primary Care Supplement

    Prognostic Value of ABPMs in patients with Treated Hypertension; Tazarotene Cream in the Treatment of Psoriasis; Antihyperglycemic Effect of Oolong Tea in Type 2 Diabetes; Metformin and Thiazolidinedione Use in Medicare Patients with Heart Failure; Alcohol Consumption Patterns and Biologic Markers of Glycemic Control; Azelaic Acid Gel as a New Treatment for Papulopustular Rosacea
  • A Critical Appraisal of Dyslipidemia Therapy

    Based on a patients lipoprotein abnormality, the algorithm described in this review begins with achievable, practical therapeutic lifestyle changes and then adds pharmacologic agents in stepwise fashion to address abnormalities of LDL cholesterol, triglycerides, and HDL cholesterol. While the approach is aggressive, it is not based on driving lipid levels to extremely low levels. While some of the lipid targets appear less stringent than conventional wisdom would suggest (eg, accepting an LDL cholesterol target of 130 mg/dL), the approach is in compliance with the spirit and letter of national guidelines.
  • Clinical Briefs in Primary Care Supplement

    A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent; Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology of Major Depressive Disorder; Urinary Tetrahydroaldosterone as a Screen for Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed Covers in Patients with Allergic Rhinitis
  • Pharmacology Watch: Vardenafil Will Compete for Share of ED Market

    The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men.
  • The Best-Seller Diets: Their Claims, Recipes, and Nutritionals

    Several excellent reviews have considered the advantages and disadvantages of popular diets, including those that feature dietary protein, but none has focused exclusively on a sample of best-seller diets, as enjoyed by the public. This article analyzes the claims of, scientific evidence for, and sustainability of 6 popular bestseller diets, along with their published recipes.
  • Pharmacology Watch: Generic Paxil Scheduled to Hit Market this Fall

    A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
  • Clinical Briefs in Primary Care Supplement

    Insulin Plus Metformin vs Triple Oral Therapy in Type 2 Diabetes; ARB and ACE-I in Diabetic Nephropathy; Low-Glycemic Index Diets and Diabetes; Ultralow-Dose Estrogen and Bone in Older Women; Effect of Intensity of Oral Anticoagulation in Atrial Fibrillation; Patient Knowledge and Awareness of Hypertension